ResearcherSapporo Medical UniversityNo recent work listed

Yuji Sakuma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2298-1359; OpenAlex author ID A5018139084. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper

Papers 1

A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells. Last author DOI 10.3892/ijo.2015.2880 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yukari Nishii · 1 shared paper, 2015 · strength 0.05
- Paper A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells. DOI 10.3892/ijo.2015.2880 ↗
Koichi Hirata · 1 shared paper, 2015 · strength 0.05
- Paper A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells. DOI 10.3892/ijo.2015.2880 ↗
Yasutoshi Kimura · 1 shared paper, 2015 · strength 0.05
- Paper A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells. DOI 10.3892/ijo.2015.2880 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.